Related Experiment Video
Updated: Aug 15, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Gadodiamide-based coronary angiography in a patient with severe renal insufficiency
1From the University of Texas Medical Branch, Galveston, Texas 77555, USA.
Insights
Gadolinium-based coronary angiography may prevent contrast-induced nephropathy (CIN) in patients with severe kidney disease. This study explored gadodiamide use and compared it with standard contrast agents.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Patients with renal insufficiency face a high risk of contrast-induced nephropathy (CIN).
- Gadolinium-based contrast agents are being investigated as a safer alternative for coronary angiography in high-risk populations.
Observation:
- This study details the use of gadodiamide-based coronary angiography in a patient with severe renal insufficiency.
- In vitro experiments compared combinations of iodinated contrast media, gadodiamide, and saline.
Findings:
- Gadolinium-based angiography was utilized in a patient with severe renal impairment.
- In vitro analysis provided comparative data on contrast agent interactions.
Implications:
- Gadolinium-based angiography presents a potential strategy for CIN prevention in at-risk patients.
- Further research is warranted to establish the safety and efficacy of gadolinium-based agents in preventing CIN.
Abstract:
The risk of contrast-induced nephropathy (CIN) is extremely high in patients with preexisting renal insufficiency. Gadolinium-based coronary angiography has been proposed as an approach to prevent CIN in this high risk subgroup. We report the use of gadodiamide-based coronary angiography in a patient with severe renal insufficiency and in vitro comparisons of combinations of iodinated contrast with gadodiamide and saline.
More Related Videos
Related Concept Videos
Imaging Studies VII: Vascular Imaging
Imaging Studies for Cardiovascular System V: CT
Cardiac Catheterization I: Pre-Procedure Overview
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

